Pharma By Number

PHARMA BY NUMBER

• Industry spend 141.6 Billion USD on R&D per year
• Drug Development for Particular Disease
  
  • o Cancer 1,813
  • o Diabetes 475
  • o HIV/AIDS 159
  • o Cardiovascular 559
• 5 of the 10 Leading global R&D firms were Research – Base Biopharmaceutical companies
• Annual Spending by the Biopharmaceutical: Industry is 5 times greater than the Defence & Aerospace Industries

PHARMA & GLOBAL HEALTH BETWEEN 2000-2008

• VACCINE HELPED REDUCE NUMBER OF MEASLES DEATH IN AFRICA BY 92%
• IN 2014 IFPMA MEMBERS HAD 186 ONGOING R&D PROJECTS REGARDING DIEASES OF THE DEVELOPING WORLD
• 88% R&D projects for NTDs are in partnerships between IFPMA members companies and +80 partners from universities, public and private sector, and NGOs
• We are 3 largest global funder in NTDs research
• Our investments in NTD research reached USD 401.2 million in 2013
• 8 R&D centers are dedicated solely to searching for new cures for NTDs
• 500 million immunized since 2000

PHARMA ECONOMIC FOOTPRINT

• Biopharmaceutical market will reach 1.3 trillion by 2018
• In 2012, Biopharmaceutical industry added USD 436.8 Billion to the world GDP similar to the economy of a country like Argentina
• The Global biopharmaceutical industry (including Generic) employed over 4.4 million and paid USD 91.3 Billion in salaries
• Global Health Partnerships IFPMA members have a strong track record in building strategic alliances for global health